Decreased Mdm2 expression inhibits tumor development induced by loss of ARF

Oncogene

Volumn 25, Issue 26, 2006, Pages 3708-3718

  Wang, P ^a   Greiner, T C ^b   Lushnikova, T ^a   Eischen, C M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

ARF; Mdm2; p53; Transformation; Tumor

Indexed keywords

ARF PROTEIN; PROTEIN MDM2; PROTEIN P53;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL IMMORTALIZATION; CELL LOSS; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATION; GROWTH INHIBITION; HAPLOTYPE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; MICE; MICE, MUTANT STRAINS; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS C-MDM2; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 33745563861     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209411     Document Type: Article

References (46)

1. Alt JR, Greiner TC, Cleveland JL, Eischen CM. (2003). EMBO J 22: 1442-1450.
2. Alt JR, Bouska A, Fernandez MR, Cerny RL, Xiao H, Eischen CM. (2005). J Biol Chem 280: 18771-18781.
3. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. (1995). Nature 377: 552-557.
4. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K et al. (1998). Science 281: 1677-1679.
5. de Rozieres S, Maya R, Oren M, Lozano G. (2000). Oncogene 19: 1691-1697.
6. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. (1995). Cell 82: 675-684.
7. Dumaz N, Meek DW. (1999). EMBO J 18: 7002-7010.
8. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. (1999). Genes Dev 13: 2658-2669.
9. Eischen CM, Rehg JE, Korsmeyer SJ, Cleveland JL. (2002). Cancer Res 62: 2184-2191.
10. Eischen CM, Alt JR, Wang P. (2004). Oncogene 23: 8931-8940.
11. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 15: 817-825.
12. Fiscella M, Ullrich SJ, Zambrano N, Shields MT, Lin D, Lees-Miller SP et al. (1993). Oncogene 8: 1519-1528.
13. Freedman DA, Levine AJ. (1998). Mol Cell Biol 18: 7288-7293.
14. Ganguli G, Wasylyk B. (2003). Mol Cancer Res 1: 1027-1035.
15. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM et al. (2002). EMBO J 21: 6225-6235.
16. Honda R, Tanaka H, Yasuda H. (1997). FEBS Lett 420: 25-27.
17. Honda R, Yasuda H. (1999). EMBO J 18: 22-27.
18. Iwakuma T, Lozano G. (2003). Mol Cancer Res 1: 993-1000.
19. Jones SN, Roe AE, Donehower LA, Bradley A. (1995). Nature 378: 206-208.
20. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV et al. (1994). Science 264: 436-440.
21. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA et al. (1997). Cell 91: 649-659.
22. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. (1998). Proc Natl Acad Sci USA 95: 8292-8297.
23. Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ. (1999). Cancer Res 59: 2217-2222.
24. Korgaonkar C, Zhao L, Modestou M, Quelle DE. (2002). Mol Cell Biol 22: 196-206.
25. Llanos S, Clark PA, Rowe J, Peters G. (2001). Nat Cell Biol 3: 445-452.
26. Lowe SW, Sherr CJ. (2003). Curr Opin Genet Dev 13: 77-83.
27. Martin-Caballero J, Flores JM, Garcia-Palencia P, Collado M, Serrano M. (2004). Oncogene 23: 8231-8237.
28. Matheu A, Pantoja C, Efeyan A, Criado LM, Martin-Caballero J, Flores JM et al. (2004). Genes Dev 18: 2736-2746.
29. Mayr GA, Reed M, Wang P, Wang Y, Schwede JF, Tegtmeyer P. (1995). Cancer Res 55: 2410-2417.
30. McDonnell TJ, Montes de Oca Luna R, Cho S, Amelse LL, Chavez-Reyes A, Lozano G. (1999). J Pathol 188: 322-328.
31. Mendrysa SM, Perry ME. (2000). Mol Cell Biol 20: 2023-2030.
32. Mendrysa SM, McElwee MK, Michalowski J, O'Leary KA, Young KM, Perry ME. (2003). Mol Cell Biol 23: 462-472.
33. Montes de Oca Luna R, Wagner DS, Lozano G. (1995). Nature 378: 203-206.
34. Moore L, Venkatachalam S, Vogel H, Watt JC, Wu CL, Steinman H et al. (2003). Oncogene 22: 7831-7837.
35. O'Leary KA, Mendrysa SM, Vaccaro A, Perry ME. (2004). Mol Cell Biol 24: 186-191.
36. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L et al. (1998). Cell 92: 713-723.
37. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. (1995). Cell 83: 993-1000.
38. Randle DH, Zindy F, Sherr CJ, Roussel MF. (2001). Proc Natl Acad Sci USA 98: 9654-9659.
39. Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ. (1998). EMBO J 17: 554-564.
40. Sherr CJ. (2001). Nat Rev Mol Cell Biol 2: 731-737.
41. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S et al. (1998). EMBO J 17: 5001-5014.
42. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H et al. (2002). Nature 415: 45-53.
43. Vousden KH. (2002). Biochim Biophys Acta 1602: 47-59.
44. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF et al. (2000). Genes Dev 14: 2358-2365.
45. Zhang Y, Xiong Y, Yarbrough WG. (1998). Cell 92: 725-734.
46. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ et al. (1998). Genes Dev 12: 2424-2433.